Andrew H. Talal

9.3k total citations · 2 hit papers
141 papers, 5.1k citations indexed

About

Andrew H. Talal is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Andrew H. Talal has authored 141 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hepatology, 85 papers in Epidemiology and 23 papers in Infectious Diseases. Recurrent topics in Andrew H. Talal's work include Hepatitis C virus research (95 papers), Liver Disease Diagnosis and Treatment (60 papers) and Hepatitis B Virus Studies (40 papers). Andrew H. Talal is often cited by papers focused on Hepatitis C virus research (95 papers), Liver Disease Diagnosis and Treatment (60 papers) and Hepatitis B Virus Studies (40 papers). Andrew H. Talal collaborates with scholars based in United States, Germany and France. Andrew H. Talal's co-authors include Ira M. Jacobson, Marija Zeremski, Charles M. Rice, Marianthi Markatou, Rositsa B. Dimova, David D. Ho, Kenneth E. Sherman, Eugene R. Schiff, Linqi Zhang and Alan S. Perelson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrew H. Talal

138 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy

1999 691 citations Andrew H. Talal et al. profile →
Neutralizing antibody response during acute and chronic hepatitis C virus infection

2004 332 citations Carine Logvinoff, Marian Major et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew H. Talal United States	35	2.9k	2.6k	1.3k	1.2k	1.0k	141	5.1k
Jacquie Astemborski United States	44	3.5k 1.2×	4.6k 1.8×	1.2k 0.9×	2.0k 1.6×	1.5k 1.4×	115	7.2k
Arthur Y. Kim United States	38	3.3k 1.1×	2.7k 1.0×	658 0.5×	1.2k 1.0×	1.1k 1.0×	121	4.9k
Margaret James Koziel United States	42	5.1k 1.8×	4.4k 1.7×	797 0.6×	1.1k 0.9×	1.4k 1.3×	98	6.8k
Philippe Halfon France	48	4.1k 1.4×	4.7k 1.8×	1.6k 1.3×	2.4k 2.0×	619 0.6×	223	7.8k
Shyam Kottilil United States	41	3.1k 1.1×	3.8k 1.5×	1.8k 1.4×	1.9k 1.5×	2.6k 2.6×	209	7.6k
Andri Rauch Switzerland	34	1.7k 0.6×	1.9k 0.7×	1.0k 0.8×	1.7k 1.4×	410 0.4×	145	3.8k
David Wong Canada	30	3.7k 1.3×	3.8k 1.4×	360 0.3×	569 0.5×	890 0.9×	126	5.6k
Francesca J. Torriani United States	32	4.1k 1.4×	5.6k 2.1×	1.0k 0.8×	1.8k 1.5×	232 0.2×	105	7.8k
Kenneth E. Sherman United States	44	6.7k 2.3×	5.8k 2.2×	690 0.5×	2.2k 1.8×	452 0.4×	250	8.7k
Massimo Puoti Italy	47	7.0k 2.4×	6.6k 2.5×	651 0.5×	2.5k 2.0×	479 0.5×	263	9.1k

Countries citing papers authored by Andrew H. Talal

Since Specialization

Citations

This map shows the geographic impact of Andrew H. Talal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Talal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Talal more than expected).

Fields of papers citing papers by Andrew H. Talal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew H. Talal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Talal. The network helps show where Andrew H. Talal may publish in the future.

Co-authorship network of co-authors of Andrew H. Talal

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew H. Talal. A scholar is included among the top collaborators of Andrew H. Talal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew H. Talal. Andrew H. Talal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalamitsis, George, et al.. (2025). Breaking the vicious cycle of delayed healthcare seeking for people who use drugs. Harm Reduction Journal. 22(1). 27–27. 2 indexed citations

Nassar, Mahmoud, et al.. (2025). Innovative approaches in predicting outcomes for rectal neuroendocrine tumors. World Journal of Gastroenterology. 31(6). 100517–100517. 1 indexed citations

Talal, Andrew H., et al.. (2025). Facilitated Telemedicine as a Patient-Centered, Sociotechnical Intervention to Integrate Hepatitis C Treatment Into Opioid Treatment Programs and Overcome the Digital Divide Among Underserved Populations: Qualitative Study. JMIR Public Health and Surveillance. 11. e68854–e68854. 1 indexed citations

González, Christopher, Shashi N. Kapadia, Jeff Niederdeppe, et al.. (2024). The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation. Journal of General Internal Medicine. 39(12). 2268–2276. 3 indexed citations

Ball, Robert, et al.. (2024). Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration. Journal of Medical Internet Research. 26. e50274–e50274. 8 indexed citations

Roussos, Sotirios, et al.. (2024). WED-478 Telehealth accessibility and acceptability among people who use drugs. Journal of Hepatology. 80. S680–S680. 1 indexed citations

Dickerson, Suzanne S., et al.. (2024). Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study. Journal of Medical Internet Research. 26. e53049–e53049. 3 indexed citations

Ventuneac, Ana, et al.. (2023). Scaling and Sustaining Facilitated Telemedicine to Expand Treatment Access Among Underserved Populations: A Qualitative Study. Telemedicine Journal and e-Health. 29(12). 1862–1869. 6 indexed citations

Talal, Andrew H., et al.. (2022). High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to Substance Users: A Mixed-Methods Study. Telemedicine Journal and e-Health. 29(3). 395–407. 15 indexed citations

10.

Talal, Andrew H., et al.. (2020). A framework for patient-centered telemedicine: Application and lessons learned from vulnerable populations. Journal of Biomedical Informatics. 112. 103622–103622. 45 indexed citations

11.

Juluru, Krishna, Andrew H. Talal, Rhonda K. Yantiss, et al.. (2016). Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd‐EOB‐DTPA‐enhanced MRI for hepatic fibrosis stage. Journal of Magnetic Resonance Imaging. 45(4). 1177–1185. 25 indexed citations

12.

Sehgal, Mohit, Marija Zeremski, Andrew H. Talal, et al.. (2015). IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment. Journal of Interferon & Cytokine Research. 35(9). 698–709. 13 indexed citations

13.

Tavakkoli, Mohammad, Stephen J. Ferrando, Judith G. Rabkin, Kristen Marks, & Andrew H. Talal. (2013). Depression and Fatigue in Chronic Hepatitis C Patients With and Without HIV Co-Infection. Psychosomatics. 54(5). 466–471. 10 indexed citations

14.

Talal, Andrew H., et al.. (2013). 1319 SIMTUZUMAB, AN ANTIFIBROTIC MONOCLONAL ANTIBODY AGAINST LYSYL OXIDASE-LIKE 2 (LOXL2) ENZYME, APPEARS SAFE AND WELL TOLERATED IN PATIENTS WITH LIVER DISEASE OF DIVERSE ETIOLOGY. Journal of Hepatology. 58. S532–S532. 17 indexed citations

15.

Talal, Andrew H., Rositsa B. Dimova, Randy Seewald, et al.. (2012). Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. Journal of Substance Abuse Treatment. 44(1). 115–119. 8 indexed citations

16.

Zeremski, Marija, Rositsa B. Dimova, Queenie B. Brown, et al.. (2009). Peripheral CXCR3‐Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. 200(11). 1774–1780. 97 indexed citations

17.

Wan, David, Kristen Marks, Rhonda K. Yantiss, & Andrew H. Talal. (2009). Autoimmune Hepatitis in the HIV-Infected Patient: A Therapeutic Dilemma. AIDS Patient Care and STDs. 23(6). 407–413. 17 indexed citations

18.

Talal, Andrew H., et al.. (2007). Changing Treatment Paradigms: Hepatitis C Virus in HIV-Infected Patients. AIDS Patient Care and STDs. 21(3). 154–168. 9 indexed citations

19.

Logvinoff, Carine, Marian Major, David Oldach, et al.. (2004). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proceedings of the National Academy of Sciences. 101(27). 10149–10154. 332 indexed citations breakdown →

20.

Talal, Andrew H., Joseph A. Murray, James A. Goeken, & William I. Sivitz. (1997). Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing.. PubMed. 92(8). 1280–4. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact